Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 50268-694

3 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 50268-694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Label 60mg Raloxifene)

Label 1 (Label 60mg Raloxifene)
Label for Raloxifene Hydrochloride Tablets, USP 60 mg, film-coated oral tablets. The label indicates prescription only and a package containing 50 tablets (5 x 10) unit dose. Manufactured by AvPAK, Pulaski, TN. Storage instructions and dispensing warnings are included.*
FDA Label Image

Chemical Structure (Raloxifene HCl Tablets Usp 1)

Chemical Structure (Raloxifene HCl Tablets Usp 1)
Chemical structure of raloxifene hydrochloride, showing the molecular arrangement including aromatic rings, a sulfur atom, hydroxyl groups, and a piperidinium chloride moiety.*
FDA Label Image

Image 1 (Raloxifene HCl Tablets Usp 2)

Image 1 (Raloxifene HCl Tablets Usp 2)
Two line graphs showing total hip mean percentage change from baseline over 24 months after randomization. The first graph compares Raloxifene HCl and placebo with percentage change on the y-axis and months on the x-axis. The second graph compares CE (conjugated estrogens 0.625 mg/day), Raloxifene HCl, and placebo for hysterectomized women. Both graphs include error bars and note intent to treat analysis with last observation carried forward.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.